Adocia SA

EPA:ADOC.PA

5.7 (EUR) • At close September 18, 2024
Bedrijfsnaam Adocia SA
Symbool ADOC.PA
Munteenheid EUR
Prijs 5.7
Beurswaarde 85,733,432
Dividendpercentage 0%
52-weken bereik 5.11 - 12.66
Industrie Biotechnology
Sector Healthcare
CEO Mr. Olivier Soula M.B.A., Ph.D.
Website https://www.adocia.com

An error occurred while fetching data.

Over Adocia SA

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform is designed and developed to optimize the performance of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such

Vergelijkbare Aandelen

Celyad Oncology SA logo

Celyad Oncology SA

CYAD.BR

0.258 EUR

Theraclion SA logo

Theraclion SA

ALTHE.PA

0.397 EUR

Visiomed Group SA logo

Visiomed Group SA

ALVMG.PA

0.173 EUR

Crossject Société Anonyme logo

Crossject Société Anonyme

ALCJ.PA

2.375 EUR

Sensorion SA logo

Sensorion SA

ALSEN.PA

0.93 EUR

ABIONYX Pharma SA logo

ABIONYX Pharma SA

ABNX.PA

1.25 EUR

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)